1. Home
  2. CVKD vs GREE Comparison

CVKD vs GREE Comparison

Compare CVKD & GREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • GREE
  • Stock Information
  • Founded
  • CVKD 2022
  • GREE 1937
  • Country
  • CVKD United States
  • GREE United States
  • Employees
  • CVKD N/A
  • GREE N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • GREE Investment Bankers/Brokers/Service
  • Sector
  • CVKD Health Care
  • GREE Finance
  • Exchange
  • CVKD Nasdaq
  • GREE Nasdaq
  • Market Cap
  • CVKD 26.3M
  • GREE 23.4M
  • IPO Year
  • CVKD 2023
  • GREE N/A
  • Fundamental
  • Price
  • CVKD $17.04
  • GREE $2.35
  • Analyst Decision
  • CVKD Strong Buy
  • GREE Strong Buy
  • Analyst Count
  • CVKD 2
  • GREE 1
  • Target Price
  • CVKD $46.00
  • GREE $4.00
  • AVG Volume (30 Days)
  • CVKD 84.2K
  • GREE 586.7K
  • Earning Date
  • CVKD 11-07-2024
  • GREE 11-07-2024
  • Dividend Yield
  • CVKD N/A
  • GREE N/A
  • EPS Growth
  • CVKD N/A
  • GREE N/A
  • EPS
  • CVKD N/A
  • GREE N/A
  • Revenue
  • CVKD N/A
  • GREE $64,382,999.00
  • Revenue This Year
  • CVKD N/A
  • GREE N/A
  • Revenue Next Year
  • CVKD N/A
  • GREE N/A
  • P/E Ratio
  • CVKD N/A
  • GREE N/A
  • Revenue Growth
  • CVKD N/A
  • GREE N/A
  • 52 Week Low
  • CVKD $5.40
  • GREE $1.62
  • 52 Week High
  • CVKD $32.55
  • GREE $9.26
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 57.77
  • GREE 52.45
  • Support Level
  • CVKD $16.25
  • GREE $2.22
  • Resistance Level
  • CVKD $19.97
  • GREE $3.09
  • Average True Range (ATR)
  • CVKD 1.80
  • GREE 0.29
  • MACD
  • CVKD -0.04
  • GREE 0.00
  • Stochastic Oscillator
  • CVKD 54.70
  • GREE 27.96

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About GREE Greenidge Generation Holdings Inc.

Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center and power generation company. The company owns and operates facilities at two locations: the Town of Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.

Share on Social Networks: